121 related articles for article (PubMed ID: 11891666)
21. The IGF-I amino-terminal tripeptide glycine-proline-glutamate (GPE) is neuroprotective to striatum in the quinolinic acid lesion animal model of Huntington's disease.
Alexi T; Hughes PE; van Roon-Mom WM; Faull RL; Williams CE; Clark RG; Gluckman PD
Exp Neurol; 1999 Sep; 159(1):84-97. PubMed ID: 10486177
[TBL] [Abstract][Full Text] [Related]
22. Increased calbindin-D28k immunoreactivity in striatal projection neurons of R6/2 Huntington's disease transgenic mice.
Sun Z; Wang HB; Deng YP; Lei WL; Xie JP; Meade CA; Del Mar N; Goldowitz D; Reiner A
Neurobiol Dis; 2005 Dec; 20(3):907-17. PubMed ID: 15990326
[TBL] [Abstract][Full Text] [Related]
23. Elevation of Met-enkephalin-like immunoreactivity in the rat striatum and globus pallidus following the focal injection of excitotoxins.
Ruzicka BB; Jhamandas K
Brain Res; 1990 Dec; 536(1-2):227-39. PubMed ID: 2150770
[TBL] [Abstract][Full Text] [Related]
24. The 1993 Upjohn Award Lecture. Quinolinic acid induced brain neurotransmitter deficits: modulation by endogenous excitotoxin antagonists.
Jhamandas KH; Boegman RJ; Beninger RJ
Can J Physiol Pharmacol; 1994 Dec; 72(12):1473-82. PubMed ID: 7736338
[TBL] [Abstract][Full Text] [Related]
25. Neuroprotection of striatal neurons against kainate excitotoxicity by neurotrophins and GDNF family members.
Gratacòs E; Pérez-Navarro E; Tolosa E; Arenas E; Alberch J
J Neurochem; 2001 Sep; 78(6):1287-96. PubMed ID: 11579137
[TBL] [Abstract][Full Text] [Related]
26. Reduced expression of preproenkephalin in striatal neurons from Huntington's disease patients.
Richfield EK; Maguire-Zeiss KA; Cox C; Gilmore J; Voorn P
Ann Neurol; 1995 Mar; 37(3):335-43. PubMed ID: 7695232
[TBL] [Abstract][Full Text] [Related]
27. Preferential loss of preproenkephalin versus preprotachykinin neurons from the striatum of Huntington's disease patients.
Richfield EK; Maguire-Zeiss KA; Vonkeman HE; Voorn P
Ann Neurol; 1995 Dec; 38(6):852-61. PubMed ID: 8526457
[TBL] [Abstract][Full Text] [Related]
28. Serotonin depletion exacerbates changes in striatal gene expression following quinolinic acid injection.
Cummings TJ; Walker PD
Brain Res; 1996 Dec; 743(1-2):240-8. PubMed ID: 9017251
[TBL] [Abstract][Full Text] [Related]
29. The role of the globus pallidus D2 subfamily of dopamine receptors in pallidal immediate early gene expression.
Marshall JF; Henry BL; Billings LM; Hoover BR
Neuroscience; 2001; 105(2):365-78. PubMed ID: 11672604
[TBL] [Abstract][Full Text] [Related]
30. Preproenkephalin messenger RNA-containing neurons in striatum of patients with symptomatic and presymptomatic Huntington's disease: an in situ hybridization study.
Albin RL; Qin Y; Young AB; Penney JB; Chesselet MF
Ann Neurol; 1991 Oct; 30(4):542-9. PubMed ID: 1838677
[TBL] [Abstract][Full Text] [Related]
31. Bilateral quinolinic acid-induced lipid peroxidation, decreased striatal monoamine levels and neurobehavioral deficits are ameliorated by GIP receptor agonist D-Ala
Verma MK; Goel R; Nandakumar K; Nemmani KVS
Eur J Pharmacol; 2018 Jun; 828():31-41. PubMed ID: 29577894
[TBL] [Abstract][Full Text] [Related]
32. Expression of D1 receptor, D2 receptor, substance P and enkephalin messenger RNAs in the neurons projecting from the nucleus accumbens.
Lu XY; Ghasemzadeh MB; Kalivas PW
Neuroscience; 1998 Feb; 82(3):767-80. PubMed ID: 9483534
[TBL] [Abstract][Full Text] [Related]
33. Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease.
Oiwa Y; Yoshimura R; Nakai K; Itakura T
Brain Res; 2002 Aug; 947(2):271-83. PubMed ID: 12176170
[TBL] [Abstract][Full Text] [Related]
34. Neuroprotective effect of interleukin-6 and IL6/IL6R chimera in the quinolinic acid rat model of Huntington's syndrome.
Bensadoun JC; de Almeida LP; Dréano M; Aebischer P; Déglon N
Eur J Neurosci; 2001 Dec; 14(11):1753-61. PubMed ID: 11860469
[TBL] [Abstract][Full Text] [Related]
35. Glial cell line-derived neurotrophic factor protects striatal calbindin-immunoreactive neurons from excitotoxic damage.
Pérez-Navarro E; Arenas E; Reiriz J; Calvo N; Alberch J
Neuroscience; 1996 Nov; 75(2):345-52. PubMed ID: 8931001
[TBL] [Abstract][Full Text] [Related]
36. Quinolinic acid elevates striatal and pallidal Met-enkephalin levels: the role of enkephalin synthesis and release.
Ruzicka BB; Day R; Jhamandas K
Brain Res; 1991 Oct; 562(1):117-25. PubMed ID: 1839239
[TBL] [Abstract][Full Text] [Related]
37. Differential regulation of the expression of nerve growth factor, brain-derived neurotrophic factor, and neurotrophin-3 after excitotoxicity in a rat model of Huntington's disease.
Canals JM; Marco S; Checa N; Michels A; Pérez-Navarro E; Arenas E; Alberch J
Neurobiol Dis; 1998 Nov; 5(5):357-64. PubMed ID: 10069578
[TBL] [Abstract][Full Text] [Related]
38. Detailed localization of regulator of G protein signaling 2 messenger ribonucleic acid and protein in the rat brain.
Taymans JM; Wintmolders C; Te Riele P; Jurzak M; Groenewegen HJ; Leysen JE; Langlois X
Neuroscience; 2002; 114(1):39-53. PubMed ID: 12207953
[TBL] [Abstract][Full Text] [Related]
39. Deficits in striatal dopamine D(2) receptors and energy metabolism detected by in vivo microPET imaging in a rat model of Huntington's disease.
Araujo DM; Cherry SR; Tatsukawa KJ; Toyokuni T; Kornblum HI
Exp Neurol; 2000 Dec; 166(2):287-97. PubMed ID: 11085894
[TBL] [Abstract][Full Text] [Related]
40. Selective activation of group I metabotropic glutamate receptors upregulates preprodynorphin, substance P, and preproenkephalin mRNA expression in rat dorsal striatum.
Mao L; Wang JQ
Synapse; 2001 Jan; 39(1):82-94. PubMed ID: 11071713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
